Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.

Saved in:
Bibliographic Details
Title: Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.
Authors: Bingham CO 3rd (AUTHOR), Buckland-Wright JC (AUTHOR), Garnero P (AUTHOR), Cohen SB (AUTHOR), Dougados M (AUTHOR), Adami S (AUTHOR), Clauw DJ (AUTHOR), Spector TD (AUTHOR), Pelletier JP (AUTHOR), Raynauld JP (AUTHOR), Strand V (AUTHOR), Simon LS (AUTHOR), Meyer JM (AUTHOR), Cline GA (AUTHOR), Beary JF (AUTHOR)
Source: Arthritis & Rheumatism. Nov2006, Vol. 54 Issue 11, p3494-3507. 14p.
Database: Academic Search Ultimate
Description
ISSN:00043591
DOI:10.1002/art.22160